Search Results

1 - 10 of 421 items :

  • "antifungals" x
Clear All
In Vitro Susceptibility Testing of Aspergillus and Non-Aspergillus Filamentous Moulds to Antifungal Agents: Evaluation of Three Different Methods

Laboratory Diagnosis of Invasive Fungal Infections. Mediterr J Hematol Infect Dis. 2011;3(1):e2011002. Epub 2011 Jan 14. 4. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49:3640-3645. 5. Murali S, Langston A. Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies. Transpl Infect Dis. 2009;11:480-490. 6

Open access
Antifungal Azole Metabolites: Significance in Pharmaceutical and Biomedical Analysis

References Eicher T, Hauptmann S. The chemistry of heterocycles: structure, reactions, syntheses, and applications. Wiley, 2nd ed. VCH, 2003: ISBN 3527307206. Lepesheva GI, Virus C, Waterman MR. Conservation in the CYP51 family: role of the B Helix/BC loop and helices F and G in enzymatic function. Bio 2003; 42: 9091-101. Pfaller MA, Riley J, Koerner T. Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of candida albicans. Diag

Open access
Topical antifungal bigels: Formulation, characterization and evaluation

REFERENCES 1. Y. C. Chen, D. Z. Liu, J. J. Liu, T. W. Chang, H. O. Ho and M. T. Sheu, Development of terbinafine solid lipid nanoparticles as a topical delivery system, Int. J. Nanomedicine 7 (2012) 4409–4418; 2. I. F. Almeida, A. R. Fernandes, L. Fernandes, M. R. Pena Ferreira, P. C. Costa and M. F. Bahia, Moisturizing effect of oleogel/hydrogel mixtures, Pharm. Dev. Technol. 13 (2008) 487–494; 3. S. Bangarwa, S. Garg and A. Aseri, A review on antifungal gels

Open access
Antifungal Susceptibility of Malassezia pachydermatis Isolates from Dogs

., Ezkurra, P. A., Quindos, G., 2006: Antifungal agents: mode of action in yeast cells. Rev. Esp. Quimioter. , 19, 2, 130—139. 5. Castelli, M. V., Butassi, E., Monteiro, M. C., Svetaz, L. A., Vicente, F., Susana, A., Zacchino, S. A., 2014: Novel anti-fungal agents: a patent review (2011—present). Expert Opin. Ther. Pat. , 24, 3, 1—16. DOI: 10.1517/13543776.2014.876993. 6. Cavana, P., Petit, J. Y., Perrot, S., Guechi, R., Marignac, G., Reynaud, K., Guillot, J., 2015: Efficacy of a 2 % climbazole shampoo for reducing Malassezia population sizes on the skin

Open access
Antifungal Effect of Selected Essential Oils on Malassezia pachydermatis Growth

. D., Puig, L., Bragulat, M. R., Castellá, G., 2016: New lipid-dependent Malassezia species from parrots. Rev. Iberoam. Micol. , 33, 92—99. 5. Carson, C. F., Hammer, K. A, Riley, T. V., 2006: Melaleuca alternifolia (Tea Tree) Oil: a Review of antimicrobial and other medicinal properties. Clin. Microbiol. Rev. , 19, 50—62. 6. Cavaleiro, C., Pinto, E., Goncalves, M. J., Salgueiro, L., 2006: Antifungal activity of Juniperus essential oils against dermatophyte, Aspergillus and Candida strains. J. Appl. Microbiol. , 100, 1333—1338. 7

Open access
Antifungal activity of a biosurfactant-producing lactic acid bacteria strain

References 1. Crowley S, Mahony J, & van Sinderen D. Comparative analysis of two antifungal Lactobacillus plantarum isolates and their application as bioprotectants in refrigerated foods. J Appl Microbiol 2012; 113: 1417-1427. 2. Schnürer J, Magnusson J. Antifungal lactic acid bacteria as biopreservatives. Trends Food Sci Technol 2005; 16: 70-8. 3. Dalié D.K.D., Deschamps A.M., Richard-Forget F. Lactic acid bacteria-Potential for control of mould growth and mycotoxins: A review. Food Control 2010; 21: 370

Open access
Antifungal Prophylaxis In Hematopoietic Stem Cell Transplant Recipients

Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis. 1999;28(5):1071-9. doi:10.1086/514731 PMID:10452637 Offner F, Cordonnier C, Ljungman P, Prentice HG, Engelhard D, De Bacquer D, Meunier F, De Pauw B. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis. 1998;26(5):1098-103. doi:10.1086/520274 PMID:9597235 Dismukes WE. Introduction to antifungal drugs. Clin Infect Dis. 2000;30:653-657. doi:10

Open access
Current status of in vitro and in vivo antifungal activities of posaconazole

References 1. Galgiani JN, Lewis ML. In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrob Agents Chemother 1997;41:180-3. 2. Pfaller MA, Messer SA, Boyken L, Hollis RJ, Rice C, Tendolkar S, et al. In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal

Open access
A preliminary study on antifungal effect of TiO2-based paints in natural indoor light

disinfection using TiO 2 films and sunlight. Water Res. 40(17), 3274-3280. DOI: 10.1016/j.waters.2006.07.006. Kim, B., Kim, D., Cho, D. & Cho, S. (2003). Bacterial effect of TiO 2 photocatalyst on selected food borne pathogenic bacteria. Chemosphere 52(1), 71-77. DOI: 10.1016/S0045-6535(03)00051-1. Maneerat, C. & Hayata, Y. (2006). Antifungal activity of TiO 2 photocatalysis against Penicillium expensum in vitro and in fruit test. Intern. J. Food Microbiol. 107(2), 99-103. DOI: 10.1016/j.ijfoodmicro.2005

Open access
Epidemiological data and antifungal susceptibility in invasive fungal infections - a Romanian infectious diseases tertiary hospital’s experience. Preliminary report

. Maschmeyer G,Patterson TF. Our 2014 aproach to breakthrough invasive fungal infections, Mycoses. 2014;57:645-51. DOI: 10.1111/myc.12213 6. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009. Diagn Microbiol Infect Dis. 2012;74(4):323-31. DOI: 10.1016/j.diagmicrobio.2012.10.003 7. Minea B, Nastasa V, Moraru RF, Kolecka A, Flonta MM

Open access